Literature DB >> 21153895

Meta-analysis of trial data may support a causal role of hyperglycaemia in cancer.

X L Yang, R C W Ma, J C N Chan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21153895     DOI： 10.1007/s00125-010-2017-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  10 in total

Review 1.  Obesity and breast cancer: progress to understanding the relationship.

Authors:  Kristy A Brown; Evan R Simpson
Journal:  Cancer Res       Date:  2009-12-22       Impact factor: 12.701

2.  Low triglyceride and nonuse of statins is associated with cancer in type 2 diabetes mellitus: the Hong Kong Diabetes Registry.

Authors:  Xilin Yang; Ronald C W Ma; Wing Yee So; Linda W L Yu; Alice P S Kong; Gary T C Ko; Gang Xu; Risa Ozaki; Peter C Y Tong; Juliana C N Chan
Journal:  Cancer       Date:  2010-10-11       Impact factor: 6.860

3.  Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials.

Authors:  J A Johnson; S L Bowker
Journal:  Diabetologia       Date:  2010-10-20       Impact factor: 10.122

4.  Fasting serum glucose level and cancer risk in Korean men and women.

Authors:  Sun Ha Jee; Heechoul Ohrr; Jae Woong Sull; Ji Eun Yun; Min Ji; Jonathan M Samet
Journal:  JAMA       Date:  2005-01-12       Impact factor: 56.272

5.  Insulin-independent promotion of chemically induced hepatocellular tumor development in genetically diabetic mice.

Authors:  Kohtaro Yamasaki; Yoshihiro Hayashi; Sumika Okamoto; Makoto Osanai; Gang-Hong Lee
Journal:  Cancer Sci       Date:  2009-09-03       Impact factor: 6.716

6.  Low LDL cholesterol, albuminuria, and statins for the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.

Authors:  Xilin Yang; Wing Yee So; Ronald C W Ma; Gary T C Ko; Alice P S Kong; Hailu Zhao; Andrea O Y Luk; Christopher W K Lam; Chung Shun Ho; Peter C Y Tong; Juliana C N Chan
Journal:  Diabetes Care       Date:  2009-07-10       Impact factor: 19.112

7.  Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.

Authors:  Xilin Yang; Gary T C Ko; Wing Yee So; Ronald C W Ma; Linda W L Yu; Alice P S Kong; Hailu Zhao; Chun-Chung Chow; Peter C Y Tong; Juliana C N Chan
Journal:  Diabetes       Date:  2010-02-25       Impact factor: 9.461

8.  Low HDL cholesterol, metformin use, and cancer risk in type 2 diabetes: the Hong Kong Diabetes Registry.

Authors:  Xilin Yang; Wing Yee So; Ronald C W Ma; Alice P S Kong; Heung Man Lee; Linda W L Yu; Chun-Chung Chow; Risa Ozaki; Gary T C Ko; Juliana C N Chan
Journal:  Diabetes Care       Date:  2010-10-27       Impact factor: 19.112

9.  Additive interaction between the renin-angiotensin system and lipid metabolism for cancer in type 2 diabetes.

Authors:  Xilin Yang; Hailu Zhao; Yi Sui; Ronald C W Ma; Wing Yee So; Gary T C Ko; Alice P S Kong; Risa Ozaki; Chun Yip Yeung; Gang Xu; Peter C Y Tong; Juliana C N Chan
Journal:  Diabetes       Date:  2009-04-28       Impact factor: 9.461

10.  Multifaceted determinants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS).

Authors:  Juliana C N Chan; Juan Jose Gagliardino; Sei Hyun Baik; Jean-Marc Chantelot; Sandra R G Ferreira; Nicolae Hancu; Hasan Ilkova; Ambady Ramachandran; Pablo Aschner
Journal:  Diabetes Care       Date:  2008-11-25       Impact factor: 17.152
  10 in total
  6 in total

Review 1.  Diabetes mellitus and metformin in hepatocellular carcinoma.

Authors:  Koji Fujita; Hisakazu Iwama; Hisaaki Miyoshi; Joji Tani; Kyoko Oura; Tomoko Tadokoro; Teppei Sakamoto; Takako Nomura; Asahiro Morishita; Hirohito Yoneyama; Tsutomu Masaki
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

2.  Methodological challenges to control for immortal time bias in addressing drug effects in type 2 diabetes.

Authors:  Xi-Lin Yang; Xiao-Xu Huo; Juliana Cn Chan
Journal:  World J Methodol       Date:  2015-09-26

3.  Fasting proinsulin levels are significantly associated with 20 year cancer mortality rates. The Hoorn Study.

Authors:  I Walraven; E van 't Riet; C D A Stehouwer; B C P Polak; A C Moll; J M Dekker; G Nijpels
Journal:  Diabetologia       Date:  2013-03-05       Impact factor: 10.122

Review 4.  Hyperinsulinemia in Obesity, Inflammation, and Cancer.

Authors:  Anni M Y Zhang; Elizabeth A Wellberg; Janel L Kopp; James D Johnson
Journal:  Diabetes Metab J       Date:  2021-03-29       Impact factor: 5.893

5.  Detection of increased serum miR-122-5p and miR-455-3p levels before the clinical diagnosis of liver cancer in people with type 2 diabetes.

Authors:  Heung Man Lee; Willy Kwun Kiu Wong; Baoqi Fan; Eric Siu Lau; Yong Hou; Chun Kwan O; Andrea On Yan Luk; Elaine Yee Kwan Chow; Ronald Ching Wan Ma; Juliana Chung Ngor Chan; Alice Pik Shan Kong
Journal:  Sci Rep       Date:  2021-12-09       Impact factor: 4.379

6.  Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum.

Authors:  Itamar Raz; Matthew C Riddle; Julio Rosenstock; John B Buse; Silvio E Inzucchi; Philip D Home; Stefano Del Prato; Ele Ferrannini; Juliana C N Chan; Lawrence A Leiter; Derek Leroith; Ralph Defronzo; William T Cefalu
Journal:  Diabetes Care       Date:  2013-06       Impact factor: 19.112
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.